The global antiinfective medicine market showed a diverse range of per capita sales in 2023. Croatia led the market with US $494.4 per capita, exhibiting a significant year-on-year increase of 22.77%. In contrast, Greece, which had the second highest sales in 2023 at US $74.7 per capita, experienced a slight decline of 0.19%. Other countries like Estonia, Norway, and Slovakia saw modest growth, whereas Canada, Sweden, and Latvia experienced declines of 3.15%, 7.63%, and 3.26% respectively. New Zealand had the highest year-on-year drop at 8.44%, reflecting a notable decrease in demand.
Future trends to watch in the global antiinfective medicine market include the impact of healthcare policies and the development of new antiinfective therapies. Emerging markets and innovations in medical technology are expected to drive sales, while economic conditions and public health initiatives may influence trends in established markets. The overall market is likely to see shifts based on regional healthcare reforms and advancements in antiinfective treatments.
Top countries in Antiinfective Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 494.4 | 2023 | +19.11% | +22.77% | View data |
| 2 | 2 Greece | 74.7 | 2023 | +0.81% | -0.19% | View data |
| 3 | 3 Estonia | 54.7 | 2023 | +14.44% | +5.48% | View data |
| 4 | 4 Norway | 54.5 | 2023 | -19.02% | +1.38% | View data |
| 5 | 5 Canada | 43.2 | 2023 | +5.88% | -3.15% | View data |
| 6 | 6 Sweden | 34.5 | 2023 | +2.99% | -7.63% | View data |
| 7 | 7 Latvia | 33.8 | 2023 | +5.3% | -3.26% | View data |
| 8 | 8 Slovakia | 30.9 | 2023 | +2.66% | +4.08% | View data |
| 9 | 9 Luxembourg | 30 | 2023 | 0% | +6.99% | View data |
| 10 | 10 Chile | 24.9 | 2023 | +10.18% | -3.14% | View data |
